Newstral
Article
Bbarrons.com on 2021-03-30 14:01
BioNTech Expects $11.5 Billion in Covid-19 Vaccine Revenue
Related news
- IBioNTech says COVID-19 vaccine raised its revenue in Q1invezz.com
BioNTech CEO expects vaccine can be fridge-stored for two weeksThe Jerusalem Post (JPost.com)
BioNTech, Pfizer’s vaccine partner, increases output goal to 2.5 billion dosestimesofisrael.com
- BBioNTech Says It Could Supply 3 Billion Doses of Its Covid-19 Vaccine Next Yearbarrons.com
Pfizer, BioNTech reach $1.95 billion vaccine deal with U.S. governmentAlaska Dispatch News
Pfizer expects $20b in COVID-19 vaccine revenue this yearSydney Morning Herald
BioNTech raises COVID vaccine target to 2.5 billion dosespressherald.com
U.S. Signs $2 Billion Vaccine Deal with Pfizer and BioNTechinfowars.com
BioNTech boss confident vaccine will ...expressandstar.com
- MBioNTech reports soaring earnings, revenue on COVID vaccine, plans $1.5 billion in buybacks 1 min readmarketwatch.com
- BEuropean Union Approves Pfizer-BioNTech Covid Vaccinebarrons.com
Pfizer, BioNTech begin Omicron vaccine trialtimesofisrael.com
- BBioNTech: Could Covid vaccine technology crack cancer?bbc.co.uk
BioNTech scientist: Vaccine could halve virus transmissionSeattle Times
EU seals deal for an extra 1.8 billion BioNTech/Pfizer vaccine doses timesofmalta.com
Pfizer, BioNTech seek COVID vaccine authorization for kidsSeattle Times
Pfizer expects $15bn sales of Covid-19 vaccineBBC
'A historic moment': Britain clears Pfizer-BioNTech COVID vaccineSydney Morning Herald
EU regulator starts review of BioNTech-Pfizer vaccinetimesofmalta.com
Pfizer/BioNTech say vaccine can be stored at warmer temperaturestimesofmalta.com